Elsevier

Biochemical Pharmacology

Volume 51, Issue 1, 12 January 1996, Pages 71-76
Biochemical Pharmacology

Reasearch paper
Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: Effects on apparent agonist affinities

https://doi.org/10.1016/0006-2952(95)02122-1Get rights and content

Abstract

Previous work has shown that 5-hydroxytryptamine (5-HT)2A receptors can be radiolabelled with various radioligands, including partial agonists, such as [125I]-DOI and [3H]-DOB, and antagonists, such as [3H]-ketanserin and [3H]-spiperone. Because 5-HT has high affinity for the 5-HT2A receptor when displacing [3H]-DOB, the purpose of the present study was to determine whether or not the receptor could be labelled with [3H]-5-HT and what would be the effect of labelling the receptor with various radioligands having differing efficacies at the receptor. Consequently, the human 5-HT2A receptor stably expressed in NIH 3T3 cells was radiolabelled with the endogenous agonist [3H]-5-HT, the partial agonist [3H]-DOB, and the antagonist [3H]-ketanserin. The receptor could be radiolabelled with [3H]-5-HT with a Kd value of 1.3 ± 0.1 nM and a Bmax value of 3461 ± 186 fmoles/mg protein and the radiolabelling was sensitive to the stable guanosine 5′-triphosphate (GTP) analogue guanylyl-imidodiphosphate (GMP-PNP). Ketanserin labeled significantly more receptors (Kd = 1.1 ± 0.1 nM: Bmax = 27684 ± 1500 fmoles/mg protein) than [3H]-DOB (Kd = 0.8 ± 0.08 nM: Bmax = 8332 ±16 fmoles/mg protein) which, in turn, labelled significantly more receptors than [3H]-5-HT. The apparent affinity of antagonists did not change when the receptor was radiolabelled with either [3H]-agonists or [3H]-antagonists; however, agonists had a higher apparent affinity for [3H]-agonist-labeled receptors than for [3H]-antagonist-labeled receptors. Therefore, the apparent affinity of agonists for the 5-HT2A receptor estimated from displacement experiments depends on the intrinsic efficacy of the radioligand used.

References (23)

  • SJ Peroutka et al.

    Multiple serotonin receptors: Differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid and [3H]spiperone

    Mol Pharmacol

    (1979)
  • Cited by (72)

    • “Selective” serotonin 5-HT<inf>2A</inf> receptor antagonists

      2022, Biochemical Pharmacology
      Citation Excerpt :

      Agonists tend to recognize these conformational states with variable affinity, making radioligand-based affinity measurements sensitive to differences in the conformation stabilized by the radioligand and competitor ligand. For example, 5-HT has higher affinity for [3H]5-HT-labeled than [3H]ketanserin-labeled 5-HT2ARs (Ki = 3.8 and 144 nM, respectively) [65]. Accordingly, the off-target binding of M100,907 is less certain than one might assume by glancing at available data in Table 1, and since competitive radioligand displacement data provide little information on ligand functional activity, some skepticism is warranted regarding the selectivity of M100,907 at 5-HT2ARs (see ref. [66] for review on defining ligand activity).

    • Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [<sup>64</sup>Cu]-DOTHA<inf>2</inf>-PEG-RM26

      2018, Nuclear Medicine and Biology
      Citation Excerpt :

      However, recent studies with receptor-selective radiolabeled antagonists have shown that such analogs may actually provide higher tumor uptake and thus be preferred over agonists for PET tumor imaging [19–22]. This has been observed with some GPCRs including serotonin 5-HT2A receptor [23], corticotrophin-releasing factor receptor [24], substance P NK1 receptor [25], and somatostatin sst3 receptor [26]. Similar results were obtained by Cescato et al. when comparing the uptakes of [99mTc]Demobesin 1 (an antagonist) with those of [99mTc]Demobesin 4 (an agonist) in GRPR-positive PC3 prostate cancer xenografts in mice [27].

    • Pharmacological modulation of abnormal involuntary DOI-induced head twitch response movements in male DBA/2J mice: II. Effects of D3 dopamine receptor selective compounds

      2015, Neuropharmacology
      Citation Excerpt :

      Competition curves were modeled for a single site and the IC50 values were converted to equilibrium dissociation constants (Ki values) by the Cheng and Prusoff (1973) correction. For these calculations the Kd value used for [3H]ketanserin labeling of the 5-HT2A receptors was 1.1 nM (Sleight et al., 1996) and the Kd value used for [3H]mesulergine labeling 5-HT2C receptors was 0.56 nM (Clarke et al., 2001). Mean Ki values ± S.E.M. are reported for at least three independent experiments.

    • Bioactive alkaloids of hallucinogenic mushrooms

      2015, Studies in Natural Products Chemistry
      Citation Excerpt :

      Other serotonin analogs display moderate to high affinity for the 5-HT1 and 5-HT2 subtypes [79–81]. It is worth mentioning that when hallucinogens are tested in competition with the receptor antagonist, it may profoundly influence apparent affinity [82]. In spite of the fact that the abuse rate is still growing, especially among young people, we know relatively little about how the hallucinogenic tryptamines affect the brain.

    View all citing articles on Scopus
    View full text